三個皮匠報告
政策庫
new
付費
搜索

AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比-行業數據

AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比
聯合化療一線治療鱗狀 NSCLC 的 3 期注冊臨床已啟動；非鱗癌的 3 期注冊臨床籌備中。
行業數據 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?6KB 圖片尺寸：1755*355
同報告圖片
 / 56
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第1頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第2頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第3頁
fCDlubTku70gICB8IOmdnuWwj+e7huiDnuiCuueZjOWPkeeXheS6uuaVsO+8iOS4h+S6uu+8iSB8CnwtLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDE2ICAgfCA2OSAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMTcgICB8IDcxICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAxOCAgIHwgNzQgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDE5ICAgfCA3NiAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjAgICB8IDc5ICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMUUgIHwgODEgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDIyRSAgfCA4NCAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjNFICB8IDg2ICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyNEUgIHwgODkgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDI1RSAgfCA5MiAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjZFICB8IDk1ICAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyN0UgIHwgOTcgICAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDI4RSAgfCAxMDAgICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjlFICB8IDEwMyAgICAgICAgICAgICAgICAgICAgICB8CnwgMjAzMEUgIHwgMTA2ICAgICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muW8l+iLpeaWr+eJueaymeWIqeaWh++8jOebiuaWueeUn+eJqeaLm+iCoeS5pu+8jOW+t+mCpueglOeptuaJgA==
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第4頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第5頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第6頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第7頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第8頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第9頁
5Lul5LiL5piv5o+Q5Y+W55qE5pWw5o2u5bm255Sf5oiQ55qE6KGo5qC877yaCgp8IOWto+W6piAgIHwg6ZSA5ZSu6aKd77yI5LiH5YWD77yJIHwKfC0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18CnwgMjAyMVEzIHwgMTEgICAgICAgICAgICAgfAp8IDIwMjFRNCB8IDcyICAgICAgICAgICAgIHwKfCAyMDIyUTEgfCA2MTIgICAgICAgICAgICB8CnwgMjAyMlEyIHwgNzE5ICAgICAgICAgICAgfAp8IDIwMjJRMyB8IDcyMSAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8mlBEQu+8jOW+t+mCpueglOeptuaJgA==
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第10頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第11頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第12頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第13頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第14頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第15頁
fOiCoeS4nOWQjeensCB85oyB6IKh5q+U5L6LIHwKfC0tLXwtLS18CnzlpI/nkZzljZrlo6vlj4rlhbbmjqfliLbms5Xlm6IgfDEyLjk5JSB8CnzmnY7nmb7li4fljZrlo6vlj4rlhbbmjqfliLbms5Xlm6IgfDYuNTAlIHwKfOeOi+W/oOawkeWNmuWjq+WPiuWFtuaOp+WItuazleWboiB8NS42MiUgfAp85aSP57695YWI55Sf77yI5Y2a5aOr77yJIHwwLjM5JSB8Cnzmib/phY3kurogfDIuODUlIHwKfOWFtuS7luiCoeS4nCB8NzEuNjUlIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOWumOe9ke+8jOWFrOWPuOWFrOWRiu+8jFdpbmTvvIzkvIHmn6Xmn6XvvIzlvrfpgqbnoJTnqbbmiYA=
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第16頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第17頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第18頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第19頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第20頁
fCDlj4LmlbAgfCDnu4TliKsxIHwg57uE5YirMiB8IOe7hOWIqzMgfCDnu4TliKs0IHwKfC0tLS0tLXwtLS0tLS18LS0tLS0tfC0tLS0tLXwtLS0tLS18CnwgVEMgICB8ICAgICAgfCAgICAgIHwgICAgICB8ICAgICAgfAp8IG5vbiBIREwtQyB8ICAgICAgfCAgICAgIHwgICAgICB8ICAgICAgfAp8IEFwb0IgIHwgICAgICB8ICAgICAgfCAgICAgIHwgICAgICB8CnwgTHAoYSkgfCAgICAgIHwgICAgICB8ICAgICAgfCAgICAgIHwKCgrotYTmlpnmnaXmupDvvJoyMDIyQUhB77yM5b636YKm56CU56m25omA
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第21頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第22頁
fCDml6XmnJ8gfCDplIDllK7ph5Hpop3vvIjkuIflhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDIxUTEgfCA5NCAgICAgICAgICAgICAgIHwKfCAyMDIxUTIgfCAxNTIgICAgICAgICAgICAgIHwKfCAyMDIxUTMgfCAxMDIgICAgICAgICAgICAgIHwKfCAyMDIxUTQgfCAyNDggICAgICAgICAgICAgIHwKfCAyMDIyUTEgfCAxLDUzNyAgICAgICAgICAgIHwKfCAyMDIyUTIgfCAyLDExOCAgICAgICAgICAgIHwKfCAyMDIyUTMgfCAzLDMzOSAgICAgICAgICAgIHwKfCAyMDIyUTQgfCAyLDkxOCAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8mlBEQu+8jOW+t+mCpueglOeptuaJgA==
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第23頁
fCDlubTku70gfCDkuYzlj7jlpbTljZXmipflhajnkIPplIDllK7pop3vvIjkur/nvo7lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDE55bm0IHwgNjMuNjEgICAgICAgICAgICAgICAgICAgICB8CnwgMjAyMOW5tCB8IDc3LjA3ICAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjHlubQgfCA5MS4zNCAgICAgICAgICAgICAgICAgICAgIHwKfCAyMDIy5bm0IHwgOTcuMjMgICAgICAgICAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrljLvoja/prZTmlrnvvIzlvrfpgqbnoJTnqbbmiYA=
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第24頁
fCDml6XmnJ8gfCDplIDllK7ph5Hpop3vvIjkuIflhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDIxUTEgfCAxODM4IHwKfCAyMDIxUTIgfCA2NDU4IHwKfCAyMDIxUTMgfCA4MDg4IHwKfCAyMDIxUTQgfCA4Nzg2IHwKfCAyMDIyUTEgfCAxMTM0OSB8CnwgMjAyMlEyIHwgMTIwODQgfAp8IDIwMjJRMyB8IDE0MDE5IHwKfCAyMDIyUTQgfCAxMTI0MCB8CgrotYTmlpnmnaXmupDvvJpQRELvvIzlvrfpgqbnoJTnqbbmiYA=
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第25頁
fCDlubTku70gfCDlj7jlupPlpYflsKTplIDllK7pop3vvIjkur/nvo7lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IDIwMTflubQgfCAyMC43MSAgICAgICAgICAgICAgICAgICAgfAp8IDIwMTjlubQgfCAyOC4zNyAgICAgICAgICAgICAgICAgICAgfAp8IDIwMTnlubQgfCAzNS41MSAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjDlubQgfCAzOS45NSAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjHlubQgfCA0Ny4xOCAgICAgICAgICAgICAgICAgICAgfAp8IDIwMjLlubQgfCA0Ny44OCAgICAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76I2v6a2U5pa577yM5b636YKm56CU56m25omA
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第26頁
fCDlsYLnuqcgfCDmlbDmja4gfAp8IC0tLSB8IC0tLSB8Cnwg55yB5Lu9IHwgMzArIHwKfCDln47luIIgfCAyMjArIHwKfCBLT0xzIHwgMzYwMCsgfAp8IERUUCB8IDUwMCsgfAp8IOWMu+mZoiB8IDE1MDArIHwKfCDliIbplIDllYYgfCAxNTArIHwKfCDpmaLlpJboja/miL8gfCA1MDArIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOWumOe9ke+8jOW+t+mCpueglOeptuaJgA==
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第27頁
fCDml6XmnJ8gfCDplIDllK7ph5Hpop3vvIjkuIflhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDIwUTQgfCAyOSAgICAgICAgICAgICAgIHwKfCAyMDIxUTEgfCA1MzkgICAgICAgICAgICAgIHwKfCAyMDIxUTIgfCAyNDcxICAgICAgICAgICAgIHwKfCAyMDIxUTMgfCA0Nzk4ICAgICAgICAgICAgIHwKfCAyMDIxUTQgfCA1OTg1ICAgICAgICAgICAgIHwKfCAyMDIyUTEgfCA3MzI2ICAgICAgICAgICAgIHwKfCAyMDIyUTIgfCA4NjMwICAgICAgICAgICAgIHwKfCAyMDIyUTMgfCAxMjA4MCAgICAgICAgICAgIHwKfCAyMDIyUTQgfCA5MjE1ICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8mlBEQu+8jOW+t+mCpueglOeptuaJgA==
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第28頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第29頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第30頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第31頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第32頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第33頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第34頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第35頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第36頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第37頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第38頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第39頁
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOiNr+WTgSAgICAgICB8IOS4reWbvemmluasoeS4iuW4guW5tOS7vSB8IOWMu+S/nSB8IOmAguW6lOeXhyB8IOayu+eWl+e6v+aVsCB8IOeUqOiNr+aWueahiCB8IOiOt+aJueaXtumXtCAgIHwKfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLS0tLS18Cnwg5biV5Y2a5Yip54+g5Y2V5oqXIHwgMjAxOCAgICAgICAgICAgICB8IOWQpiAgIHwg6L2s56e75oCn6Z2e6bOeTlNDTEMgfCDkuIDnur8gICAgIHwg6IGU5ZCI5Z+5576O5puy5aGeK+mTguexu+WMlueWlyB8IDIwMTkvNC8yICAgfAp8ICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgIHwgICAgICB8IFBELUwxIFRQU+KJpTEl77yMRUdGUi9BTEvpmLTmgKfnmoQgfCDkuIDnur8gICAgIHwg5Y2V6I2vICAgICAgIHwgMjAxOS8xMC8yICB8CnwgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgfCAgICAgIHwg5bGA6YOo5pma5pyf5oiW6L2s56e75oCnTlNDTEMgfCAgICAgICAgICB8ICAgICAgICAgICAgfCAgICAgICAgICAgIHwKfCAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICB8ICAgICAgfCDovaznp7vmgKfogrrps57nirbnu4bog57nmYwgfCDkuIDnur8gICAgIHwg6IGU5ZCI5Y2h6ZOC5Y+K57Sr5p2J6YaHKOeZveibi+eZvee7k+WQiOWei+e0q+adiemGhykgfCAyMDE5LzExLzI2IHwKfCDnurPmrabliKnlsKTljZXmipcgfCAyMDE4ICAgICAgICAgICAgIHwg5ZCmICAgfCBFR0ZSL0FMS+mYtOaAp+eahO+8jOaXouW+gOWQq+mTguWMlueWl+Wksei0peeahOWxgOmDqOaZmuacn+aIlui9rOenu+aAp05TQ0xDIHwg5LqM57q/5Y+K5Lul5ZCOIHwg5Y2V6I2vICAgICAgIHwgMjAxOC82LzE1ICB8CnwgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgfCAgICAgIHwg55So5LqO5Y+v5YiH6Zmk55qE77yI6IK/55ik4omlNGNt5oiW5reL5be057uT6Ziz5oCn77yJTlNDTEMgfCDmlrDovoXliqkgICAgfCDljZXoja8gICAgICAgfCAyMDIzLzEvMTcgIHwKfCDnibnnkZ7mma7liKnljZXmipcgfCAyMDE4ICAgICAgICAgICAgIHwg5pivICAgfCBFR0ZSL0FMS+mYtOaAp+WxgOmDqOaZmuacn+aIlui9rOenu+aAp+mdnumznueKtk5TQ0xDIHwg5LiA57q/ICAgICB8IOiBlOWQiOWfuee+juabsuWhnuWSjOWNoemTgiB8IDIwMjIvOS8xNCAgfAp8IOS/oei/quWIqeWNleaKlyAgfCAyMDE4ICAgICAgICAgICAgIHwg5pivICAgfCBFR0ZSL0FMS+mYtOaAp+eahOaZmuacn+mdnumznueKtk5TQ0xDIHwg5LiA57q/ICAgICB8IOiBlOWQiOWfuee+juabsuWhnuWSjOWNoemTgiB8IDIwMjEvMi8yICAgfAp8ICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgIHwgICAgICB8IEVHRlIvQUxL6Zi05oCn5bGA6YOo5pma5pyf5oiW6L2s56e75oCn6bOe54q2TlNDTEMgfCDkuIDnur8gICAgIHwg6IGU5ZCI5ZCJ6KW/5LuW5ruoK+mTguexu+WMlueWlyB8IDIwMjEvNi8zICAgfAp8IOabv+mbt+WIqeePoOWNleaKlyB8IDIwMTkgICAgICAgICAgICAgfCDmmK8gICB8IEVHRlIvQUxL6Zi05oCn55qE5LiN5Y+v5omL5pyv5YiH6Zmk55qE5bGA6YOo5pma5pyf5oiW6ICF6L2s56e75oCn6Z2e6bOe55mMTlNDTEMgfCDkuIDnur8gICAgIHwg6IGU5ZCI5Z+5576O5puy5aGe5ZKM6ZOC57G7IHwgMjAyMS82LzIyICB8CnwgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgfCAgICAgIHwg5pma5pyf6IK66bOe55mMIHwg5LiA57q/ICAgICB8IOiBlOWQiOWNoemTguWPiue0q+adiemGhyjnmb3om4vnmb3nu5PlkIjlnovntKvmnYnphocpIHwgMjAyMS8xLzEyICB8CnwgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgfCAgICAgIHwg6bOe55mM5ZKM6Z2e6bOe55mMTlNDTEMgfCDkuoznur/lj4rku6XlkI4gfCDljZXoja8gICAgICAgfCAyMDIyLzEvNSAgIHwKfCDljaHnkZ7liKnnj6DljZXmipcgfCAyMDE5ICAgICAgICAgICAgIHwg5pivICAgfCBFR0ZSL0FMS+mYtOaAp+eahOaZmuacn+mdnumznueKtk5TQ0xDIHwg5LiA57q/ICAgICB8IOiBlOWQiOWfuee+juabsuWhnuWSjOWNoemTgiB8IDIwMjAvNi8yMiAgfAp8ICAgICAgICAgICAgfCAgICAgICAgICAgICAgICAgIHwgICAgICB8IEVHRlIvQUxL6Zi05oCn55qE5pma5pyf6bOe54q2TlNDTEMgfCDkuIDnur8gICAgIHwg6IGU5ZCI57Sr5p2J6YaH5ZKM5Y2h6ZOCIHwgMjAyMS8xMi84ICB8Cnwg6LWb5biV5Yip5Y2V5oqXICB8IDIwMjEgICAgICAgICAgICAgfCDlkKYgICB8IOWxgOmDqOaZmuacn+aIlui9rOenu+aAp+mznueKtk5TQ0xDIHwg5LiA57q/ICAgICB8IOiBlOWQiOe0q+adiemGh+WSjOWNoemTgiB8IDIwMjMvMS8xNiAgfAp8IOa0vuWuieaZruWIqeWNleaKlyB8IDIwMjEgICAgICAgICAgICAgfCDlkKYgICB8IOWxgOmDqOaZmuacn+aIlui9rOenu+aAp+mznueKtk5TQ0xDIHwg5LiA57q/ICAgICB8IOiBlOWQiOeZveibi+eZvee0q+adiemGh+WSjOWNoemTgiB8IDIwMjIvMTAvMjUgfAp8IOaWr+mygeWIqeWNleaKlyAgfCAyMDIyICAgICAgICAgICAgIHwg5ZCmICAgfCDlsYDpg6jmmZrmnJ/miJbovaznp7vmgKfps57nirZOU0NMQyB8IOS4gOe6vyAgICAgfCDogZTlkIjnmb3om4vnmb3ntKvmnYnphoflkozljaHpk4IgfCAyMDIyLzEwLzI1IHwKfCDmma7nibnliKnljZXmipcgIHwgMjAyMiAgICAgICAgICAgICB8IOWQpiAgIHwg5bGA6YOo5pma5pyf5oiW6L2s56e75oCn6bOe54q2TlNDTEMgfCDkuIDnur8gICAgIHwg6IGU5ZCI55m96JuL55m957Sr5p2J6YaH5ZKM5Y2h6ZOCIHwgMjAyMi8xMC8yNSB8CgrotYTmlpnmnaXmupDvvJrljLvoja/prZTmlrnvvIzlvrfpgqbnoJTnqbbmiYA=
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第40頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第41頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第42頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第43頁
fCBBSzExMiDmgLvplIDllK7pop0v5Lq/5YWDIHwgMjAyM0UgfCAyMDI0RSB8IDIwMjVFIHwgMjAyNkUgfCAyMDI3RSB8IDIwMjhFIHwgMjAyOUUgfCAyMDMwRSB8IDIwMzFFIHwgMjAzMkUgfCAyMDMzRSB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS18LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18LS0tLS0tLXwtLS0tLS0tfC0tLS0tLS18LS0tLS0tLXwKfCBBSzExMiDmgLvplIDllK7pop0v5Lq/5YWDIHwgMy4xOSAgfCAxMi40NyB8IDMwLjE3IHwgNTAuMDQgfCA0OS43NSB8IDQ5LjQxIHwgNDYuNjAgfCA0Ni44OSB8IDQ1LjQ0IHwgNDYuMTkgfCAgICAgICB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jlrpjnvZHvvIwyMDIyIENTQ08g5oyH5Y2X77yM5YGl5bq355WM77yM546w5Luj5Yy76I2v5Y2r55Sf77yM5Lq65rCR5Y+377yM44CKQ29tcGFyYXRpdmUgU3R1ZHkgb2YgUEQtTDEgRXhwcmVzc2lvbiBpbiBEaWZmZXJlbnQgU2l0ZXMgb2YgTm9uLXNtYWxsIENlbGwgTHVuZyBDYW5jZXLjgIs=
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第44頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第45頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第46頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第47頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第48頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第49頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第50頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第51頁
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IEFLMTAxIOebiOWIqemihOa1iyB8IDIwMjNFIHwgMjAyNEUgfCAyMDI1RSB8IDIwMjZFIHwgMjAyN0UgfCAyMDI4RSB8IDIwMjlFIHwgMjAzMEUgfCAyMDMxRSB8IDIwMzJFIHwgMjAzM0UgfAp8LS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS18Cnwg6ZO25bGR55eF5oKj6ICF5pWwL+S4h+S6uiB8IDY2MyAgICB8IDY3MCAgICB8IDY3NiAgICB8IDY4MyAgICB8IDY5MCAgICB8IDY5NyAgICB8IDcwNCAgICB8IDcxMSAgICB8IDcxOCAgICB8IDcyNSAgICB8IDc1NCAgICB8Cnwg5Lit6YeN5bqm6ZO25bGR5Y2g5q+UICAgIHwgNjAlICAgIHwgNjAlICAgIHwgNjAlICAgIHwgNjAlICAgIHwgNjAlICAgIHwgNjAlICAgIHwgNjAlICAgIHwgNjAlICAgIHwgNjAlICAgIHwgNjAlICAgIHwgNjAlICAgIHwKfCDkuK3ph43luqbpk7blsZHnl4XmgqPogIXmlbAv5LiH5Lq6IHwgMzk4ICAgIHwgNDAyICAgIHwgNDA2ICAgIHwgNDEwICAgIHwgNDE0ICAgIHwgNDE4ICAgIHwgNDIyICAgIHwgNDI3ICAgIHwgNDMxICAgIHwgNDM1ICAgIHwgNDUzICAgIHwKfCDnlJ/nianliLbliYLmuJfpgI/njocgICAgfCAxMCUgICAgfCAxMiUgICAgfCAxNCUgICAgfCAxNiUgICAgfCAxOCUgICAgfCAyMCUgICAgfCAyMiUgICAgfCAyNCUgICAgfCAyNiUgICAgfCAyOCUgICAgfCAzMCUgICAgfAp8IOaOpeWPl+eUn+eJqeWItuWJguayu+eWl+eahOaCo+iAheaVsC/kuIfkurogfCA0MCAgICAgfCA0OCAgICAgfCA1NyAgICAgfCA2NiAgICAgfCA3NSAgICAgfCA4NCAgICAgfCA5MyAgICAgfCAxMDIgICAgfCAxMTIgICAgfCAxMjIgICAgfCAxMzYgICAgfAp8IElMLTEyL0lMLTIzIOa4l+mAj+eOhyB8IDE1JSAgICB8IDE3JSAgICB8IDIwJSAgICB8IDIzJSAgICB8IDI1JSAgICB8IDI3JSAgICB8IDI4JSAgICB8IDI5JSAgICB8IDMwJSAgICB8IDMwJSAgICB8IDMwJSAgICB8Cnwg5o6l5Y+XIElMLTEyL0lMLTIzIOayu+eWl+eahOaCo+iAheaVsC/kuIfkurogfCA2ICAgICAgfCA4ICAgICAgfCAxMSAgICAgfCAxNSAgICAgfCAxOSAgICAgfCAyMyAgICAgfCAyNiAgICAgfCAzMCAgICAgfCAzNCAgICAgfCAzNyAgICAgfCA0MSAgICAgfAp8IEFLMTAxIOW4guWNoOeOhyAgICAgIHwgMTAlICAgIHwgMjAlICAgIHwgMzUlICAgIHwgMzUlICAgIHwgMzIlICAgIHwgMzAlICAgIHwgMjclICAgIHwgMjUlICAgIHwgMjMlICAgIHwgMjElICAgIHwgICAgICAgIHwKfCDlubTlnYfmsrvnlpfotLnnlKgv5LiH5YWDICB8IDIuNTAgICB8IDIuMDAgICB8IDIuMDAgICB8IDEuODAgICB8IDEuODAgICB8IDEuNjIgICB8IDEuNjIgICB8IDEuNDYgICB8IDEuNDYgICB8IDEuNDYgICB8ICAgICAgICB8CnwgQUsxMDEg6ZSA5ZSu6aKdL+S6v+WFgyAgfCAyLjA1ICAgfCA0LjU1ICAgfCAxMC41NiAgfCAxMS43NCAgfCAxMy4wMSAgfCAxMi42NCAgfCAxMi45OSAgfCAxMi4yNSAgfCAxMi4yNiAgfCAxMi40NyAgfCAgICAgICAgfAp8IOiOt+aJueamgueOhyAgICAgICAgICB8IDkwJSAgICB8IDkwJSAgICB8IDkwJSAgICB8IDkwJSAgICB8IDkwJSAgICB8IDkwJSAgICB8IDkwJSAgICB8IDkwJSAgICB8IDkwJSAgICB8IDkwJSAgICB8ICAgICAgICB8Cnwg6aOO6Zmp6LCD5pW05ZCO6ZSA5ZSu6aKdL+S6v+WFgyB8IDEuODQgICB8IDQuMDkgICB8IDkuNTAgICB8IDEwLjU2ICB8IDExLjcxICB8IDExLjM4ICB8IDExLjY5ICB8IDExLjAyICB8IDExLjAzICB8IDExICAgICB8ICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jlrpjnvZHvvIzmlrDop4bnur/vvIzmlrDljY7npL7vvIzljLvlrabnlYzvvIzoja/mmbrmlbDmja7vvIwyMeS4lue6que7j+a1juaKpemBk+etie+8jOW+t+mCpueglOeptuaJgOa1i+eulw==
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第52頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第53頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第54頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第55頁
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第56頁
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
AK112與帕博利珠單抗在鱗癌與非鱗癌的臨床數據對比_第57頁
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
所屬報告： 康方生物~B-港股公司研究報告-自主商業化驗證+大單品出海持續進化的新一代創新藥龍頭-230507（52頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站